TCMD NASDAQ
Tactile Systems Technology, Inc.
1W: +11.2%
1M: +2.7%
3M: -10.8%
YTD: -6.5%
1Y: +146.4%
3Y: +24.2%
5Y: -53.0%
$24.90
-0.73 (-2.85%)
Weekly Expected Move ±7.3%
$19
$21
$23
$24
$26
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (36)
Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference
Should Value Investors Buy Tactile Systems Technology (TCMD) Stock?
Tactile Medical projects $360M-$368M 2026 revenue as Medicare prior authorization process matures
Tactile Systems Technology, Inc. Q1 2026 Earnings Call Summary
Tactile Systems (TCMD) Q1 2026 Earnings Transcript
Full Transcript: Tactile Systems Tech Q1 2026 Earnings Call
Tactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue Estimates
Tactile Systems (TCMD) Q2 2025 Earnings Transcript
Tactile (TCMD) Q1 2025 Earnings Transcript
Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results
Earnings Scheduled For May 4, 2026
DexCom (DXCM) Q1 Earnings and Revenues Top Estimates
EW's Q1 Earnings Beat, Revenues Match, '26 View Up, Stock Climbs
Tactile Systems Technology (NASDAQ:TCMD) Stock Passes Below 50 Day Moving Average – Should You Sell?
BSX Q1 Earnings Match, '26 View Down, Stock Gains in Premarket
BSX Q1 Earnings Match, '26 View Down, Stock Gains in Premarket
Quest Diagnostics' Q1 Earnings & Revenues Top Estimates, Stock Up
Tactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Rating of “Moderate Buy” from Brokerages
Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings
Should Value Investors Buy Tactile Systems Technology (TCMD) Stock?
3 Medical Instrument Stocks Tapping GenAI to Navigate Industry Woes
CWA Asset Management Group LLC Buys Shares of 54,722 Tactile Systems Technology, Inc. $TCMD
Tactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Rating of “Moderate Buy” from Analysts
Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer
Wall Street Analysts See a 41.11% Upside in Tactile Systems Technology (TCMD): Can the Stock Really Move This High?
Tactile Systems Technology (TCMD) is an Incredible Growth Stock: 3 Reasons Why
Tactile Medical Strengthens Board of Directors with Appointment of Andrea Pearson
Wall Street Analysts Think Tactile Systems Technology (TCMD) Could Surge 28.34%: Read This Before Placing a Bet
Are Investors Undervaluing Tactile Systems Technology (TCMD) Right Now?
3 Reasons Why Growth Investors Shouldn't Overlook Tactile Systems Technology (TCMD)
Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio
Tactile Medical to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 17, 2026
Tactile Systems Technology (TCMD) is a Great Momentum Stock: Should You Buy?
Are Medical Stocks Lagging Tactile Systems Technology (TCMD) This Year?